Zanthoxylum rhetsa Metabolites Demonstrate Potent Anti-Prostate Cancer Activity: Insights From in Vitro Screening and Molecular Docking Study
Authors:
- Linda Mensah SarpongLSLinda Mensah Sarpong
- Akwasi AcheampongAAAkwasi Acheampong
- Mercy BaduMBMercy Badu
- Jibira YakubuJYJibira Yakubu
- Kennedy Ameyaw BaahKBKennedy Ameyaw Baah
- Silas AdjeiSASilas Adjei
- Emmanuel Quaye KontohEKEmmanuel Quaye Kontoh
- Joseph Adusei-SarkodieJAJoseph Adusei-Sarkodie
- Isaac Kingsley AmponsahIAIsaac Kingsley Amponsah
- Samuel Oppong BekoeSBSamuel Oppong Bekoe
- 6 June 2026
- journal article
- Published by Springer Nature in Chemistry Africa
- Vol. 9 (5)
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Vinca alkaloids as a potential cancer therapeutics: recent update and future challenges3 Biotech, 2023
- Lupenone is a good anti-inflammatory compound based on the network pharmacologyMolecular Diversity, 2019
- Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with AntiandrogensJournal of Urology, 2018
- CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2The Journal of Steroid Biochemistry and Molecular Biology, 2017
- A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum)European Journal of Pharmacology, 2017
- Beneficial health effects of lupeol triterpene: A review of preclinical studiesLife Sciences, 2011
- Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies, 2004
- Chemical Constituents from the Leaves of Zanthoxylum SchinifoliumJournal of the Chinese Chemical Society, 2002
- Constituents and cytotoxicity of Zanthoxylum rhesta stem barkFitoterapia, 2000
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997